| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.005 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |